ANTI-TNF AGENTS AND VEDOLIZUMAB HAVE SIMILAR SAFETY AS FIRST-LINE BIOLOGIC TREATMENT OF ELDERLY PATIENTS WITH ULCERATIVE COLITIS
Noy Nachmias Peiser 1
Tamar Thurm 1
Nathaniel Aviv Cohen 1
Ayal Hirsch 1
Yulia Ron 1
Nitsan Maharshak 1
1 Tel Aviv Sourasky Medical Center, Tel Aviv, Israel
Topic
IBD
Session
PP 05 IBD (Posters)
Conference
UEG Week 2023
Citation
United European Gastroenterology Journal 2023; 11 (Supplement 8)
Login to access library content
Do you need help setting up your myUEG account?
Contact us at [email protected]